España
India
Italia
대한민국
日本
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
India
Italia
대한민국
日本
Login
Register
Our Services
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
News
Earnings
Guidance
Dividends
M&A
Buybacks
Legal
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Markets
Pre-Market
After Hours
Movers
ETFs
Forex
Cannabis
Commodities
Binary Options
Bonds
Futures
CME Group
Global Economics
Mining
Previews
Small-Cap
Real Estate
Penny Stocks
Digital Securities
Volatility
Options
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
From The Press
Jim Cramer
Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Crypto
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Recent
Markets
Comments
Close menu
Loading...
Day One Biopharmaceutical
DAWN
NASDAQ
Watchlist
Leave a Comment
Logo brought to you by Benzinga Data
Get Report
Perks
Buy
Compare Brokers
Get Report
Perks
Buy
Compare Brokers
$12.00
-0.13
-1.07%
Pre-Market: 4:35 PM EDT
Get Report
Comment
Q4 2024 Earnings in 12 days from now on Tue Feb 25th, after the market close
Day One Biopharmaceutical (DAWN) Forecast
News
Earnings
Day One Biopharmaceutical (DAWN) Options
Guidance
Dividends
Analyst Ratings
Insider Trades
Short Interest
Latest news for Day One Biopharmaceutical (NASDAQ:DAWN) Stock
Day One Biopharmaceutical Stock (NASDAQ: DAWN)
Categories: All
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
All News
General
Contracts
Dividends
Events
FDA
M&A
Offerings
Stock Split
Media
Buybacks
Insider Trades
Earnings
Guidance
Analyst Ratings
Trading Ideas
Monday, February 10, 2025
Goldman Sachs Maintains Buy on Day One Biopha...
Benzinga Newsdesk
Monday, January 13, 2025
Needham Reiterates Buy on Day One Biopharmace...
Benzinga Newsdesk
Day One Biopharmaceuticals Announces $57.2M P...
Benzinga Newsdesk
Tuesday, January 07, 2025
B of A Securities Maintains Buy on Day One Bi...
Benzinga Newsdesk
Thursday, October 31, 2024
HC Wainwright & Co. Reiterates Buy on Day One...
Benzinga Newsdesk
Why Carvana Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Needham Reiterates Buy on Day One Biopharmace...
Benzinga Newsdesk
Wednesday, October 30, 2024
Day One Biopharmaceuticals shares are trading...
Benzinga Newsdesk
Day One Biopharmaceutical Q3 2024 GAAP EPS $0...
Benzinga Newsdesk
Wednesday, October 09, 2024
Needham Maintains Buy on Day One Biopharmaceu...
Benzinga Newsdesk
Friday, September 20, 2024
Watching Shares Of Day One Biopharmaceuticals...
Benzinga Newsdesk
Wednesday, August 28, 2024
Day One Biopharmaceuticals Files For Offering...
Benzinga Newsdesk
Tuesday, August 06, 2024
JP Morgan Maintains Overweight on Day One Bio...
Benzinga Newsdesk
Thursday, August 01, 2024
Meta To Rally Around 35%? Here Are 10 Top Analyst Forecasts For Thursday
Avi Kapoor
Day One Biopharmaceuticals shares are trading...
Benzinga Newsdesk
HC Wainwright & Co. Reiterates Buy on Day One...
Benzinga Newsdesk
B of A Securities Upgrades Day One Biopharmac...
Benzinga Newsdesk
Wednesday, July 31, 2024
Needham Maintains Buy on Day One Biopharmaceu...
Benzinga Newsdesk
Tuesday, July 30, 2024
Needham Reiterates Buy on Day One Biopharmace...
Benzinga Newsdesk
Day One Biopharmaceutical Q2 2024 GAAP EPS $(...
Benzinga Newsdesk
Day One Biopharmaceuticals Announced An Overs...
Benzinga Newsdesk
Friday, July 26, 2024
HC Wainwright & Co. Reiterates Buy on Day One...
Benzinga Newsdesk
Thursday, July 25, 2024
Why Indivior Shares Are Trading Higher; Here Are 20 Stocks Moving Premarket
Avi Kapoor
Ipsen And Day One Earlier Announced Exclusive...
Benzinga Newsdesk
Ipsen And Day One Enter Ex-U.S. Licensing Dea...
Benzinga Newsdesk
Monday, July 08, 2024
Piper Sandler Maintains Overweight on Day One...
Benzinga Newsdesk
Thursday, June 20, 2024
HC Wainwright & Co. Reiterates Buy on Day One...
Benzinga Newsdesk
Wednesday, June 19, 2024
Needham Reiterates Buy on Day One Biopharmace...
Benzinga Newsdesk
Tuesday, June 18, 2024
Day One Biopharmaceuticals Enters Exclusive L...
Benzinga Newsdesk
Thursday, May 30, 2024
Day One To Sell Priority Review Voucher For $...
Benzinga Newsdesk
Tuesday, May 07, 2024
HC Wainwright & Co. Maintains Buy on Day One ...
Benzinga Newsdesk
Needham Reiterates Buy on Day One Biopharmace...
Benzinga Newsdesk
Monday, May 06, 2024
Day One Biopharmaceutical Q1 2024 GAAP EPS $(...
Benzinga Newsdesk
Thursday, April 25, 2024
Needham Reiterates Buy on Day One Biopharmace...
Benzinga Newsdesk
Wednesday, April 24, 2024
HC Wainwright & Co. Reiterates Buy on Day One...
Benzinga Newsdesk
Needham Maintains Buy on Day One Biopharmaceu...
Benzinga Newsdesk
Tuesday, April 23, 2024
Day One's OJEMDA Receives U.S. FDA Accelerate...
Benzinga Newsdesk
Monday, April 22, 2024
JP Morgan Maintains Overweight on Day One Bio...
Benzinga Newsdesk
Tuesday, March 26, 2024
Piper Sandler Maintains Overweight on Day One...
Benzinga Newsdesk
Wednesday, February 28, 2024
Piper Sandler Maintains Overweight on Day One...
Benzinga Newsdesk
Tuesday, February 27, 2024
Goldman Sachs Maintains Buy on Day One Biopha...
Benzinga Newsdesk
Oppenheimer Reiterates Perform on Day One Bio...
Benzinga Newsdesk
Monday, February 26, 2024
Day One Cash, Cash Equivalents And Short-Term...
Benzinga Newsdesk
Friday, November 17, 2023
Day One Biopharmaceuticals Reveals Tovorafeni...
Benzinga Newsdesk
Tuesday, November 07, 2023
Analyst Ratings for Day One Biopharmaceutical
Benzinga Insights
Wedbush Maintains Outperform on Day One Bioph...
Benzinga Newsdesk
Needham Reiterates Buy on Day One Biopharmace...
Benzinga Newsdesk
Monday, November 06, 2023
Day One Biopharmaceutical Q3 EPS $(0.54) Down...
Benzinga Newsdesk
Monday, October 30, 2023
Western Digital, JinkoSolar, Lumentum Holdings And Other Big Stocks Moving Higher On Monday
Lisa Levin
Market-Moving News for October 30th
Benzinga Newsdesk
Show More
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started
People Also Watch
